ibrutinib
abbvie,janssen
['lymphoma', 'mantle,(-dismantle)', 'janssen', 'janssenglobal']
data presented at #asco22 put s #imbruvica out in front of other btk inhibitor for the first-line mantle cell lymphoma indication. 
The leading voice for decision-makers throughout the global biopharma ecosystem. 
Free weekly podcast "BioCentury This Week": https://t.co/6CfHh0mIT6